Neogen Corp (NEOG): Total Assets
$3.35B
As of 2026-05-31
-9.8%
3-year compound annual growth
+29.5%
5-year compound annual growth
+22.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-05-31 | $3.35B | -2.8% | 2026-07-30, Balance as of period end |
| 2025-05-31 | $3.44B | -24.3% | 2026-07-30, Balance as of period end |
| 2024-05-31 | $4.55B | -0.1% | 2025-07-30, Balance as of period end |
| 2023-05-31 | $4.55B | +358.7% | 2025-07-30, Balance as of period end |
| 2022-05-31 | $992.93M | +7.9% | 2024-07-30, Balance as of period end |
| 2021-05-31 | $920.19M | +15.4% | 2023-08-15, Balance as of period end |
| 2020-05-31 | $797.18M | +14.6% | 2022-07-27, Balance as of period end |
| 2019-05-31 | $695.74M | +12.6% | 2021-07-30, Balance as of period end |
| 2018-05-31 | $618.01M | +17.0% | 2020-07-30, Balance as of period end |
| 2017-05-31 | $528.41M | +17.4% | 2019-07-30, Balance as of period end |
| 2016-05-31 | $449.94M | +14.7% | 2018-07-27, Balance as of period end |
| 2015-05-31 | $392.18M | +13.6% | 2017-07-28, Balance as of period end |
| 2014-05-31 | $345.30M | +18.8% | 2016-07-29, Balance as of period end |
| 2013-05-31 | $290.56M | +15.5% | 2015-07-30, Balance as of period end |
| 2012-05-31 | $251.60M | +14.5% | 2014-07-30, Balance as of period end |
| 2011-05-31 | $219.66M | +21.9% | 2013-07-30, Balance as of period end |
| 2010-05-31 | $180.23M | n/a | 2012-07-30, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Neogen Corp (NEOG) | 2026-05-31 | $3.35B | -2.8% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $706.60M | -31.2% |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $2.23B | +12.5% |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $5.77B | -10.2% |
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $3.35B | +1.7% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $842.13M | -29.3% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $103.58M | -12.8% |
| Immucell Corp (ICCC) | 2025-12-31 | $42.53M | -5.7% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $5.46M | -0.6% |
Compare NEOG, MYGN, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗